Allogene Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | — | -157.9% | -159.6% |
| FY2022 | — | -215,087.2% | -218,214.1% |
| FY2023 | — | -344,986.3% | -344,489.5% |
| FY2024 | — | -1,241,813.6% | -1,170,863.6% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | — | -157.9% | -159.6% |
| FY2022 | — | -215,087.2% | -218,214.1% |
| FY2023 | — | -344,986.3% | -344,489.5% |
| FY2024 | — | -1,241,813.6% | -1,170,863.6% |